HUMIRA Adalimumab Injection
Facts of HUMIRA Adalimumab Injection 40 mg ?
- Medicine Name: HUMIRA
- Generic Name: Adalimumab
- Approval Date: Dec 31, 2002
- Company Name: Abbot Laboratories
- Available as (Form & Strength): 40 mg injection
What are the indications and usage?
HUMIRA is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. HUMIRA can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs)